Survience Research and Consulting

Survience Research and Consulting

Prajin Ravindran, Managing Partner & Director

Prajin Ravindran

Managing Partner & Director

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials Usage of Conversational AI in the Health Insurance Sector The Future of Kidney Transplants in India Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Pharma: Embracing Continuous Manufacturing AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality The Future of Medicine: Harnessing the Power of RNA-based Therapeutics The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Impact of Human Factors Engineering on Medical Device Safety Top 10 Retail Pharmacies In India - 2024 | Pharma Outlook

Editor's Guest

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts
Jaideep Gogtay, Global Chief Medical Officer, Cipla

Fostering a Quality Culture in the Pharmaceutical Industry
Dr. S. Eswara Reddy, Joint Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO)

Changing Landscape for LTBI and Syndromic Testing Methodologies
Manoj Jagathmohan, Director & Head, India & South Asia, QIAGEN